2023 Compounding Controlled Substances 
Pharmacy Times
JUNE 5, 2025
1,2 New products are entering the market that could be poised to revolutionize the inventory counting process for pharmacists and health care providers, especially for controlled substances.
Drug Topics
JUNE 10, 2025
In 2023, they distributed 360,000 syringes and needles through their syringe service program. Drug paraphernalia includes all equipment, products, and materials of any kind intended for manufacturing, using, or storing controlled substances. About The Author Peter A.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OctariusRx
FEBRUARY 20, 2023
The 2023 controlled substance assessment quiz is about to be released! This is our first annual competency assessment focused on controlled substances and regulatory compliance. The quiz focuses on some of the basic elements managing controlled substances. How are you assessing your staff?
The FDA Law Blog
FEBRUARY 28, 2023
Houck — The Drug Enforcement Administration’s (“DEA’s”) February 13th determination that THC acetate ester (“THCO”) is a schedule I controlled substance under the federal Controlled Substances Act (“CSA”) has received a good amount of attention in the cannabis press. 13, 2023). By Larry K. Terrence L. Boos, Ph.D.,
OctariusRx
NOVEMBER 20, 2023
The 2023 version of the OctariusRx USP 800 assessment quiz is about to be released! With the enforcement of USP Chapter 800 beginning on November 1, 2023, facilities will be required to assess staff competency on an annual basis. The post The 2023 USP 800 Assessment Quiz appeared first on OctariusRX. Contact us for assistance.
The FDA Law Blog
AUGUST 21, 2023
Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).
The Happy PharmD
OCTOBER 11, 2024
Despite its substantial revenue of $24 billion in 2023, Rite Aid faced a steady decline leading to its eventual bankruptcy filing. Compounding its challenges, Rite Aid became entangled in legal issues, notably linked to the opioid crisis.
Expert insights. Personalized for you.
Let's personalize your content